Follow

Aker BioMarine ASA

Aker BioMarine is a biotech innovator and Antarctic krill-harvesting company, developing krill-based ingredients for nutraceutical, aquaculture, and animal feed applications. The company’s fully transparent value chain stretches from sustainable krill harvesting in pristine Antarctic waters through its Montevideo logistics hub, Houston production plant, and all the way to customers around the world. The company is dedicated to improving human and planetary Health.

Sector:
INDUSTRIALS
>
Food Producers
Sector:
CONSUMER STAPLES
>
Farming, Fishing, Ranching & Plantations
Status
This company has moved to a main market, therfore we do not show updates relating to this company.
News
No available news yet for Aker BioMarine ASA
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived

NB! Information about past events and all documents are available for signed in users who have bought those events.

Type
Ticker
ISIN
Market
SHARE
AKBM
NO0010886625
Details of share in Aker BioMarine ASA with ticker AKBM
Status
Active
Currency
NOK
Listing
Sign in to buy
Market move
Sign in to buy
Type
Ticker
ISIN
Market
SHARE
AKBM-ME
NO0010886625
Euronext Growth Oslo
Norway (NO)
Details of share in Aker BioMarine ASA with ticker AKBM-ME
Status
Archived
Currency
NOK
Listing
Sign in to buy
Type
Ticker
ISIN
Market
SHARE
AKBM
NO0010886625
Details of share in Aker BioMarine ASA with ticker AKBM
Status
Active
Currency
NOK
Market move
Sign in to buy
People
Matts Eirik Johansen
CEO
Ola Snøve
Chairman of the board
Øyvind Eriksen
Board member
Kjell Inge Røkke
Board member
Frank Ove Reite
Board member
Julie Hoff
Board member
Sindre Skjong
Board member
Company Details
Sector
INDUSTRIALS, CONSUMER STAPLES

Address
Oksenøyveien 10
Zip code
1366
City/district
Lysaker
Country
Norway (NO)
Registration number
913 915 062
LEI code
549300V34T6VWDSYWE64
First trade date
06 Jul 2020
Registration date
21 Jul 2014
Short name
AKBM

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More